Maryland · 2026 Regular Session · Bill

SB 435: Public Health - Medetomidine and Xylazine Consumer Protection Act

In committee Last action April 13, 2026: Motion Laid Over (Senator Ready) Adopted

Plain-language summary

SB 435 is a bill introduced in the Maryland Senate on January 30, 2026. According to its official title, it concerns: Public Health - Medetomidine and Xylazine Consumer Protection Act. Primary sponsor: Bill Folden (Republican). Most recent recorded action (April 13, 2026): Motion Laid Over (Senator Ready) Adopted.

Sponsors

Primary sponsor: Bill Folden (Republican).